Ratings Change: Bioventix Plc (LON:BVXP) “Corporate” Rating Reiterated by finnCap; With GBX 1450.00 Target

November 29, 2016 - By Marguerite Chambers

Bioventix Plc (LON:BVXP) Rating

In a note released on Tuesday morning, Bioventix Plc (LON:BVXP) stock had its “Corporate” Rating maintained by expert analysts at finnCap. They currently have a GBX 1450.00 target price on company. finnCap’s target would suggest a potential upside of 5.45% from the company’s close price.

About 377 shares traded hands. Bioventix PLC (LON:BVXP) has risen 33.17% since May 2, 2016 and is uptrending. It has outperformed by 27.91% the S&P500.

Bioventix PLC, based in the United Kingdom, is engaged in the development and supply of antibodies. The company has a market cap of 70.11 million GBP. The Firm is a biotechnology firm specializing in the development of high-affinity sheep monoclonal antibodies for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing. It has a 19.55 P/E ratio. The Firm uses its technology in the fields of clinical diagnostics.

More important recent Bioventix PLC (LON:BVXP) news were published by: Fool.Co.Uk which released: “Why I Would Buy Bioventix Plc Over GlaxoSmithkline Plc And AstraZeneca Plc” on April 28, 2015, also Fool.Co.Uk published article titled: “Should I Invest In Bioventix PLC, Flybe Group PLC And Tasty Plc Now?”, Uk.Finance.Yahoo.com published: “-LSE Ticker: 4QVDF0/ISIN: GB00B4QVDF07” on April 10, 2010. More interesting news about Bioventix PLC (LON:BVXP) was released by: Fool.Co.Uk and their article: “3 Solid Small-Caps Set To Fly? Tasty Plc, Bioventix PLC And Alkane Energy Plc” with publication date: April 30, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>